A L Kovac

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial
    A L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City 66160 7415, USA
    J Clin Anesth 11:453-9. 1999
  2. ncbi Management of postoperative nausea and vomiting in children
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Paediatr Drugs 9:47-69. 2007
  3. ncbi Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Cardiothorac Vasc Anesth 21:45-50. 2007
  4. ncbi Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Clin Anesth 18:304-18. 2006
  5. ncbi Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Mail Stop 1034, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    Ann Pharmacother 40:873-87. 2006
  6. ncbi The prophylactic treatment of postoperative nausea and vomiting in oral and maxillofacial surgery
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 1034, Kansas City, KS 66160, USA
    J Oral Maxillofac Surg 63:1531-5. 2005
  7. ncbi Sugammadex: the first selective binding reversal agent for neuromuscular block
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Clin Anesth 21:444-53. 2009
  8. ncbi Prevention and treatment of postoperative nausea and vomiting
    A L Kovac
    Department of Anaesthesiology, University of Kansas Medical Center, Kansas City 66160 7415, USA
    Drugs 59:213-43. 2000
  9. ncbi Comparison of nicardipine versus placebo to control hemodynamic responses during emergence and extubation
    A L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160 7415, USA
    J Cardiothorac Vasc Anesth 15:704-9. 2001
  10. ncbi Effect of distance and infusion rate on operation of Medfusion 2010 infusion pump during magnetic resonance imaging
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160 7415, USA
    J Clin Anesth 14:246-51. 2002

Detail Information

Publications17

  1. ncbi Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial
    A L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City 66160 7415, USA
    J Clin Anesth 11:453-9. 1999
    ..To compare repeat intravenous (i.v.) dosing of ondansetron 4 mg with placebo for the treatment of postoperative nausea and vomiting (PONV) in patients for whom prophylactic, preoperative ondansetron 4 mg i.v. was inadequate..
  2. ncbi Management of postoperative nausea and vomiting in children
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Paediatr Drugs 9:47-69. 2007
    ..Reference to and the use of PONV guidelines and management algorithms help improve cost-effective postoperative care...
  3. ncbi Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Cardiothorac Vasc Anesth 21:45-50. 2007
    ..The purpose of this study was to compare the effectiveness of intravenous (IV) nicardipine versus esmolol in controlling heart rate (HR) and blood pressure (BP) responses to emergence and extubation...
  4. ncbi Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Clin Anesth 18:304-18. 2006
    ..A brief overview of the incidence, risk factors and current management recommendations for PONV and current controversies with special emphasis on the 5-HT3 receptor antagonists, is discussed...
  5. ncbi Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Mail Stop 1034, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
    Ann Pharmacother 40:873-87. 2006
    ..To assess the use of rescue antiemetic medication following 5-HT3 receptor antagonist (5-HT3RA) plus dexamethasone therapy versus monotherapy with a 5-HT3RA for prophylaxis of postoperative nausea and vomiting (PONV)...
  6. ncbi The prophylactic treatment of postoperative nausea and vomiting in oral and maxillofacial surgery
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 1034, Kansas City, KS 66160, USA
    J Oral Maxillofac Surg 63:1531-5. 2005
  7. ncbi Sugammadex: the first selective binding reversal agent for neuromuscular block
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    J Clin Anesth 21:444-53. 2009
    ..In October 2007, a new drug application for sugammadex was submitted to the U.S. Food and Drug Administration (FDA). The FDA issued a not-approvable letter in July 2008. The manufacturer continues clinical trials...
  8. ncbi Prevention and treatment of postoperative nausea and vomiting
    A L Kovac
    Department of Anaesthesiology, University of Kansas Medical Center, Kansas City 66160 7415, USA
    Drugs 59:213-43. 2000
    ....
  9. ncbi Comparison of nicardipine versus placebo to control hemodynamic responses during emergence and extubation
    A L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160 7415, USA
    J Cardiothorac Vasc Anesth 15:704-9. 2001
    ..To compare 2 different doses of intravenous nicardipine versus placebo to control heart rate and blood pressure responses to emergence and extubation...
  10. ncbi Effect of distance and infusion rate on operation of Medfusion 2010 infusion pump during magnetic resonance imaging
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160 7415, USA
    J Clin Anesth 14:246-51. 2002
    ..Duluth, GA) at distances of 2, 4, 8, 12, and 16 feet from a 1.5 Tesla MRI magnet over a four-week time interval, using infusion rates that would correspond to those of propofol administration...
  11. ncbi Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting
    Anthony L Kovac
    Department of Anesthesiology, University of Kansas Medical Center, Kansas City 66160 7415, USA
    Drug Saf 26:227-59. 2003
    ..The clinician must weigh the benefit of administering an antiemetic for CINV or PONV against the risk of occurrence of an adverse event...
  12. ncbi A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period
    Anthony L Kovac
    Department of Anesthesiology, University of KS Medical Center, Kansas City, KS, USA
    Anesth Analg 107:439-44. 2008
    ....
  13. ncbi A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting
    Tong J Gan
    Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA
    Anesth Analg 108:1498-504. 2009
    ..We sought to determine whether the use of transdermal scopolamine (TDS) in combination with IV ondansetron (OND) is more effective than one alone for reducing PONV in outpatient settings...
  14. ncbi Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group
    B K Philip
    Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Clin Anesth 12:1-8. 2000
    ..e., maximum efficacy with minimum adverse events) for prevention of postoperative nausea and vomiting (PONV) using the statistical power generated in a pooled patient sample from three large, nearly identical clinical trials...
  15. ncbi A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting
    Keith A Candiotti
    Department of Anesthesiology, University of Miami, Miami, Florida, USA
    Anesth Analg 107:445-51. 2008
    ....
  16. ncbi Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting
    Tong J Gan
    Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Anesth Analg 105:1615-28, table of contents. 2007
    ....
  17. ncbi Is there rationale to use an antiemetic in the same class for the treatment of patients who experience postoperative nausea and vomiting despite prophylaxis?
    Anthony L Kovac
    Anesth Analg 97:1857. 2003